104307-49-5Relevant academic research and scientific papers
CANNABINOID DERIVATIVES
-
Paragraph 0137, (2021/01/23)
The present disclosure relates to a carmabinoid derivative, a pharmaceutical composition comprising it, as well as its use in the treatment and prevention of diseases associated with a carmabinoid receptor in a subject in need thereof, such as acute pain, ADHD/ ADD, alcohol use disorder, allergic asthma, ALS, Alzheimer's, anorexia, etc. The carmabinoid derivative has the following formula:
Synthesis of Further Divarinol and Olivetol Lichen para-Depsides
Elix, John A.,Parker, John L.,Tearne, Philip D.,Wardlaw, Judith H.
, p. 1863 - 1871 (2007/10/02)
The lichen depsides 2-O-methyldivaricatic acid (1), 3-chlorodivaricatic acid (2), 4-O-demethylstenoporic acid (3), 2-O-methylstenosporic acid (4), 4-O-demethylimbricaric acid (5) and 3,5-dichloro-2'-O-methylanziaic (6) have been prepared by unambigous syn
